BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 29080395)

  • 1. MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro.
    Li F; Liang A; Lv Y; Liu G; Jiang A; Liu P
    Med Sci Monit; 2017 Oct; 23():5139-5149. PubMed ID: 29080395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-200c inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3.
    Liu L; Qiu M; Tan G; Liang Z; Qin Y; Chen L; Chen H; Liu J
    J Transl Med; 2014 Nov; 12():305. PubMed ID: 25367080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.
    Wang X; Chen X; Wang R; Xiao P; Xu Z; Chen L; Hang W; Ruan A; Yang H; Zhang X
    Oncol Rep; 2013 Aug; 30(2):643-50. PubMed ID: 23754305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1.
    Dong P; Kaneuchi M; Watari H; Hamada J; Sudo S; Ju J; Sakuragi N
    Mol Cancer; 2011 Aug; 10():99. PubMed ID: 21851624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-218 regulates the epithelial-to-mesenchymal transition and the PI3K/Akt signaling pathway to suppress lung adenocarcinoma progression by directly targeting BMI-1.
    Xu L; Sun HB; Xu ZN; Han XL; Yin YY; Zheng Y; Zhao Y; Wang ZX
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7978-7988. PubMed ID: 31599423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-195 inhibits migration, invasion and epithelial-mesenchymal transition (EMT) of endometrial carcinoma cells by targeting SOX4.
    Zhao X; Dai L; Yue Q; Wang H; Wang XU; Li Y; Chen R
    J Biosci; 2019 Dec; 44(6):. PubMed ID: 31894127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma.
    Li Q; Zhang C; Chen R; Xiong H; Qiu F; Liu S; Zhang M; Wang F; Wang Y; Zhou X; Xiao G; Wang X; Jiang Q
    Cancer Lett; 2016 Dec; 383(1):28-40. PubMed ID: 27693631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of microRNA-194 suppresses the epithelial-mesenchymal transition in targeting stem cell transcription factor Sox3 in endometrial carcinoma stem cells.
    Gong B; Yue Y; Wang R; Zhang Y; Jin Q; Zhou X
    Tumour Biol; 2017 Jun; 39(6):1010428317706217. PubMed ID: 28618953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
    Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
    J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-183 induces epithelial-mesenchymal transition and promotes endometrial cancer cell migration and invasion in by targeting CPEB1.
    Xiong H; Chen R; Liu S; Lin Q; Chen H; Jiang Q
    J Cell Biochem; 2018 Nov; 119(10):8123-8137. PubMed ID: 29923214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment.
    Liu S; Tetzlaff MT; Wang T; Yang R; Xie L; Zhang G; Krepler C; Xiao M; Beqiri M; Xu W; Karakousis G; Schuchter L; Amaravadi RK; Xu W; Wei Z; Herlyn M; Yao Y; Zhang L; Wang Y; Zhang L; Xu X
    Pigment Cell Melanoma Res; 2015 Jul; 28(4):431-41. PubMed ID: 25903073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells.
    Chen S; Chen X; Sun KX; Xiu YL; Liu BL; Feng MX; Sang XB; Zhao Y
    PLoS One; 2016; 11(11):e0165776. PubMed ID: 27829043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-10b Directly Targets ZEB1 and PIK3CA to Curb Adenomyotic Epithelial Cell Invasiveness via Upregulation of E-Cadherin and Inhibition of Akt Phosphorylation.
    Guo Y; Lang X; Lu Z; Wang J; Li T; Liao Y; Jia C; Zhao W; Fang H
    Cell Physiol Biochem; 2015; 35(6):2169-80. PubMed ID: 25896413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-203 inhibits epithelial-mesenchymal transition, migration, and invasion of renal cell carcinoma cells via the inactivation of the PI3K/AKT signaling pathway by inhibiting CAV1.
    Han N; Li H; Wang H
    Cell Adh Migr; 2020 Dec; 14(1):227-241. PubMed ID: 32990143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the role of hsa-miR-200c in reversing the epithelial to mesenchymal transition in prostate cancer.
    Basu S; Chaudhary A; Chowdhury P; Karmakar D; Basu K; Karmakar D; Chatterjee J; Sengupta S
    Gene; 2020 Mar; 730():144264. PubMed ID: 31759982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-200c regulates invasion, proliferation and EMT of anaplastic thyroid cancer cells by targeting parathyroid hormone like hormone.
    Zhang Y; Duan Y; Wu C; Peng W; Chen W; Wang L; Deng Z
    Growth Factors; 2022 Nov; 40(5-6):175-185. PubMed ID: 36067091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-205 promotes epithelial-mesenchymal transition by targeting AKT signaling in endometrial cancer cells.
    Jin C; Liang R
    J Obstet Gynaecol Res; 2015 Oct; 41(10):1653-60. PubMed ID: 26446417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced PLOD2 regulates invasion and epithelial-mesenchymal transition in endometrial carcinoma cells.
    Wan J; Qin J; Cao Q; Hu P; Zhong C; Tu C
    Genes Genomics; 2020 Mar; 42(3):317-324. PubMed ID: 31872384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer.
    Zhou X; Hu Y; Dai L; Wang Y; Zhou J; Wang W; Di W; Qiu L
    PLoS One; 2014; 9(5):e96718. PubMed ID: 24816687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.